These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2169975)

  • 21. The incidence and clinical features of heparin-induced thrombocytopenia.
    Bartholomew JR
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S3-8. PubMed ID: 16105557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass].
    Párama JA; Llorens R; Sáenz de Buruaga J; Rocha E
    Med Clin (Barc); 1994 Apr; 102(16):637-8. PubMed ID: 8208043
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of heparin-induced thrombocytopenia and thrombosis.
    Green RM
    Semin Vasc Surg; 1996 Dec; 9(4):292-5. PubMed ID: 8958605
    [No Abstract]   [Full Text] [Related]  

  • 24. Low molecular weight heparins--a safer option than unfractionated heparin?
    McKay GA; Paterson KR
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):256-76. PubMed ID: 11770172
    [No Abstract]   [Full Text] [Related]  

  • 25. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Heparin-induced thrombopenia: significance and difficulties of precise identification of the immunologic mechanism].
    Samama MM; Elalamy I; Lecrubier C; Potevin F; Horellou MH; Conard J
    Bull Acad Natl Med; 1998; 182(7):1517-33; discussion 1534-6. PubMed ID: 9916345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-molecular-weight heparin in pregnancy.
    Kittisupamongkol W
    Am J Obstet Gynecol; 2009 Sep; 201(3):e12; author reply e12. PubMed ID: 19439265
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical significance and problems of treatment of patients with heparin-induced thrombocytopenia].
    Barkagan ZS
    Ter Arkh; 1999; 71(7):72-6. PubMed ID: 10481872
    [No Abstract]   [Full Text] [Related]  

  • 29. Low-molecular-weight heparin and thrombocytosis: a further reason to monitor the platelet count.
    Prescrire Int; 2003 Oct; 12(67):183. PubMed ID: 14619899
    [No Abstract]   [Full Text] [Related]  

  • 30. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
    Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombopenia caused by fraxiparin. A case].
    Ball A; L'Huillier AM; Dreyfuss L; Porte JP; Barthel JC
    Presse Med; 1989 Jun; 18(25):1254. PubMed ID: 2544872
    [No Abstract]   [Full Text] [Related]  

  • 32. Need for more intensive treatment of patients with acute pulmonary embolism caused by heparin-induced thrombocytopaenia Type II.
    Antonijevic NM; Milosevic R; Perunicic J; Stanojevic M; Calija B; Vasiljevic Z
    Eur Heart J; 2005 Dec; 26(24):2745-6. PubMed ID: 16230301
    [No Abstract]   [Full Text] [Related]  

  • 33. A rare case of HITTS following prophylactic LMWH therapy in a blunt trauma victim.
    Barnes SL; Bernard AC; Kearney PA; Boulanger BR
    Injury; 2005 Feb; 36(2):347-51. PubMed ID: 15664603
    [No Abstract]   [Full Text] [Related]  

  • 34. [Low molecular weight heparin in a patient with pulmonary embolism and heparin-induced thrombocytopenia].
    Monreal M; Torrabadella P; Roncales J; Torguet P
    Med Clin (Barc); 1988 Nov; 91(16):638-9. PubMed ID: 2852738
    [No Abstract]   [Full Text] [Related]  

  • 35. Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay.
    Bryant A; Low J; Austin S; Joseph JE
    Br J Haematol; 2008 Dec; 143(5):721-6. PubMed ID: 19036016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autoimmune thrombocytopenia from low molecular weight heparin].
    Recarte García-Andrade C; Pastor Gómez-Cornejo L
    An Med Interna; 1998 Jun; 15(6):339-40. PubMed ID: 9656520
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
    Baroletti S; Piovella C; Fanikos J; Labreche M; Lin J; Goldhaber SZ
    Thromb Haemost; 2008 Dec; 100(6):1130-5. PubMed ID: 19132240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia.
    Chan M; Malynn E; Shaz B; Uhl L
    Am J Hematol; 2008 Mar; 83(3):212-7. PubMed ID: 17910041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Daily thrombocyte count in low molecular weight heparin treatment].
    Spannagl M
    Chirurg; 2008 Mar; Suppl():85. PubMed ID: 18711818
    [No Abstract]   [Full Text] [Related]  

  • 40. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism.
    Stein PD; Hull RD; Matta F; Yaekoub AY; Liang J
    Am J Med; 2009 Oct; 122(10):919-30. PubMed ID: 19682670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.